瘤免疫中的细胞外囊泡:机制和新的见解
Liwen Kuang1, Lei Wu2, Yongsheng Li3,4
1School of Medicine, Chongqing University, Chongqing, China.
Molecular cancer
|February 14, 2025
概括
细胞外囊泡 (EVs) 在癌症中起着双重作用,帮助瘤免疫逃避,但也为免疫疗法提供了潜力. 了解电动汽车的理解
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 细胞外囊泡 (EVs) 是由参与细胞间通信的细胞分泌的纳米级囊泡.
- EVs在瘤免疫调节中发挥着重要作用,影响瘤进展和免疫反应.
- 它们在免疫逃避中的参与和作为免疫治疗剂的潜力是研究的一个关键领域.
研究的目的:
- 描述细胞外囊泡 (EV) 在瘤免疫调节中的复杂作用.
- 探索EVs作为治疗标和癌症免疫治疗中的药剂的潜力.
- 为推进未来基于EVs的癌症免疫疗法策略提供见解.
主要方法:
- 文献综述和现有关于细胞外囊泡和瘤免疫力的研究的分析.
- 对EVs在瘤微环境中的生物特征和功能的检查.
- 综合有关EVs在免疫逃避和免疫激活中的双重作用的信息.
主要成果:
- EVs具有双重作用:它们可以通过帮助免疫逃避和转移来促进瘤的进展.
- 相反,EV也可以刺激抗瘤免疫反应,提供治疗机会.
- 电动汽车的特定载荷和功能对于确定它们对瘤免疫力的影响至关重要.
结论:
- 细胞外囊泡 (EVs) 是新型癌症免疫治疗策略的一个有希望的前沿.
- 针对或利用电动汽车可以提高治疗效率和患者的治疗结果.
- 对EV生物学和功能进行进一步的研究对于开发基于EV的有效癌症治疗是必不可少的.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cytotoxic T Cells-mediated Immune Response
830
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
830
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Cancer Vaccines
327
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
327


